Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

Odey Pan European GBP R

Ranked 73 out of 83 in - Europe over 12 months
All calculations are in GBP

Managed by

Crispin Odey

Crispin Odey graduated from Christ Church College, Oxford in 1980 where he studied history and economics. He started managing funds with Framlington Fund Managers before joining Baring Asset Management where he ran retail and pension funds. Crispin established Odey Asset Management in 1991 and is head of investment management. He runs the CF Odey Opus Fund, investing in global equity and fixed interest stocks.

Objective

The investment objective of the Sub-Fund is long term capital appreciation through investing in equities issued by companies which derive a significant proportion of their income from or whose principal offices are in Europe, including Eastern Europe (“European companies”). The Sub-Fund will invest primarily in equities issued by what the Investment Manager considers to be companies which derive a significant proportion of their income from or whose principal offices are in Europe, including Eastern Europe (“European companies”) which are listed or traded on one or more Recognised Exchanges.

Performance

Europe over : 30/09/2013 - 30/09/2014

Total Return

Quarterly Performance

to 30/09/2014 Annual Q1 Q2 Q3 Q4
2014 -5.7% 1.3% -3.8% -3.3%
2013 29.6% 12.0% 2.8% 7.8% 4.5%
2012 18.6% 12.1% -7.7% 4.8% 9.3%
2011 -13.4% 5.2% 4.2% -22.2% 1.5%
2010 10.9% 8.4% -12.1% 7.0% 8.7%
2009 12.0% -15.6% 15.2% 27.3% -9.4%
2008 2.9% 2.4% -4.2% -11.3% 18.3%
2007 17.8% 4.4% 8.0% 0.7% 3.7%
2006 0.7% -10.5% 4.5% 7.6%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. Austria
  2. Ireland
  3. Spain
  4. Switzerland
  5. United Kingdom

Fund Info

  • Launch date21/03/2006
  • Share Class size20Mn
  • Base currencyGBP
  • ISIN IE00B15JZT25

Purchase Info

  • Min. initial investment5,000
  • Min. additional investment0

Charges

  • Annual management1.5%

Related News

Odey buys £70m stake in biotech new boy

The hedge fund guru's investment boutique bought a 12% stake in cat allergy specialist Circassia Pharmaceuticals on its 13 March IPO.

Killik urges clients to look for safe havens in 2009

Killik & Co, the wealth manager, says companies with strong balance sheets will not only  be better prepared to survive the downturn, but will also be able to increase their market share.

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in GBP).